How to Approach Chronic Inducible Urticaria.
Maurer M, Fluhr JW, Khan DA.
J Allergy Clin Immunol Pract. 2018 Jul-Aug;6(4):1119-1130. doi: 10.1016/j.jaip.2018.03.007.
Chronic inducible urticaria: classification and prominent features of physical and non-physical types.
Pozderac I, Lugović-Mihić L, Artuković M, Stipić-Marković A, Kuna M, Ferček I.
Acta Dermatovenerol Alp Pannonica Adriat. 2020 Sep;29(3):141-148.
Biomarkers of Autoimmune Chronic Spontaneous Urticaria.
Larenas-Linnemann D.
Curr Allergy Asthma Rep. 2023 Dec;23(12):655-664. doi: 10.1007/s11882-023-01117-7. Epub 2023 Dec 8.
New insights into chronic inducible urticaria.
Muñoz M, Kiefer LA, Pereira MP, Bizjak M, Maurer M.
Curr Allergy Asthma Rep. 2024 Aug;24(8):457-469. doi: 10.1007/s11882-024-01160-y. Epub 2024 Jul 19.
Vibratory Urticaria and ADGRE2.
Boyden SE, Metcalfe DD, Komarow HD.
N Engl J Med. 2016 Jul 7;375(1):95. doi: 10.1056/NEJMc1604757.
Vibratory Urticaria and ADGRE2.
Kaplan AP, Greenberger PA, Geller M.
N Engl J Med. 2016 Jul 7;375(1):94-5. doi: 10.1056/NEJMc1604757.
Inhibition of KIT for chronic urticaria: a status update on drugs in early clinical development.
Wedi B.
Expert Opin Investig Drugs. 2023 Jul-Dec;32(11):1043-1054. doi: 10.1080/13543784.2023.2277385. Epub 2023 Nov 24.
Anti-KIT antibody, barzolvolimab, reduces skin mast cells and disease activity in chronic inducible urticaria.
Terhorst-Molawi D, Hawro T, Grekowitz E, Kiefer L, Merchant K, Alvarado D, Thomas LJ, Hawthorne T, Crowley E, Heath-Chiozzi M, Metz M, Maurer M.
Allergy. 2023 May;78(5):1269-1279. doi: 10.1111/all.15585. Epub 2022 Dec 3.
CAPS and NLRP3.
Booshehri LM, Hoffman HM.
J Clin Immunol. 2019 Apr;39(3):277-286. doi: 10.1007/s10875-019-00638-z. Epub 2019 May 10.
Periodic fever syndromes.
Lachmann HJ.
Best Pract Res Clin Rheumatol. 2017 Aug;31(4):596-609. doi: 10.1016/j.berh.2017.12.001. Epub 2018 Jan 11.
